ArticleSheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi2026
[A protein-ligand binding affinity prediction model integrating multi-scale interaction features].
Article in Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protein-ligand binding affinity prediction is critical for drug development, where rapid and accurate assessment of drug-target binding remains a key challenge. Deep learning-based modeling provides a more efficient and scalable solution compared to traditional experimental approaches. This paper proposes a multi-scale interaction feature fusion model for protein-ligand binding affinity prediction, named the multi-scale binding affinity predictor (MSBind). The MSBind model employed multiple attention mechanisms to extract both global and local interaction features between the protein-ligand complex. By jointly modeling this multi-scale information, it ultimately enhanced the model's predictive performance. Experimental results showed that on the PDBbind v2016 core dataset, the root mean square error of MSBind was only 1.23, which was significantly lower than the baselines, demonstrating superior predictive accuracy. Furthermore, dimensionality reduction visualization of the extracted interaction features provided additional validation of the interpretability and effectiveness of MSBind. In summary, by integrating multi-scale interaction features, MSBind provides a high-performance solution for protein-ligand binding affinity prediction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.